- Home
- Healthcare
- Genetic Obesity Drug Market
Genetic Obesity Drug Market Size, Share, Growth, and Industry Analysis, By Type (Sibutramine, Orlistat, Sympathomimetic Drugs, Receptors Antagonists, and Others), By Application (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others), and Regional Forecast to 2033
Region: Global | Format: PDF | Report ID: PMI1866 | SKU ID: 26433129 | Pages: 129 | Published : April, 2024 | Base Year: 2024 | Historical Data: 2020 - 2023
Detailed TOC of Global Genetic Obesity Drug Market Research Report 2024(Status and Outlook)
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Genetic Obesity Drug
1.2 Key Market Segments
1.2.1 Genetic Obesity Drug Segment by Type
1.2.2 Genetic Obesity Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Genetic Obesity Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Genetic Obesity Drug Market Size (M USD) Estimates and Forecasts (2019-2031)
2.1.2 Global Genetic Obesity Drug Sales Estimates and Forecasts (2019-2031)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Genetic Obesity Drug Market Competitive Landscape
3.1 Global Genetic Obesity Drug Sales by Manufacturers (2019-2024)
3.2 Global Genetic Obesity Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Genetic Obesity Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Genetic Obesity Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Genetic Obesity Drug Sales Sites, Area Served, Product Type
3.6 Genetic Obesity Drug Market Competitive Situation and Trends
3.6.1 Genetic Obesity Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Genetic Obesity Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Genetic Obesity Drug Industry Chain Analysis
4.1 Genetic Obesity Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Genetic Obesity Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Genetic Obesity Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Genetic Obesity Drug Sales Market Share by Type (2019-2024)
6.3 Global Genetic Obesity Drug Market Size Market Share by Type (2019-2024)
6.4 Global Genetic Obesity Drug Price by Type (2019-2024)
7 Genetic Obesity Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Genetic Obesity Drug Market Sales by Application (2019-2024)
7.3 Global Genetic Obesity Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Genetic Obesity Drug Sales Growth Rate by Application (2019-2024)
8 Genetic Obesity Drug Market Segmentation by Region
8.1 Global Genetic Obesity Drug Sales by Region
8.1.1 Global Genetic Obesity Drug Sales by Region
8.1.2 Global Genetic Obesity Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Genetic Obesity Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Genetic Obesity Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Genetic Obesity Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Genetic Obesity Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Genetic Obesity Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Pfizer, Inc.
9.1.1 Pfizer, Inc. Genetic Obesity Drug Basic Information
9.1.2 Pfizer, Inc. Genetic Obesity Drug Product Overview
9.1.3 Pfizer, Inc. Genetic Obesity Drug Product Market Performance
9.1.4 Pfizer, Inc. Business Overview
9.1.5 Pfizer, Inc. Genetic Obesity Drug SWOT Analysis
9.1.6 Pfizer, Inc. Recent Developments
9.2 Sanofi.
9.2.1 Sanofi. Genetic Obesity Drug Basic Information
9.2.2 Sanofi. Genetic Obesity Drug Product Overview
9.2.3 Sanofi. Genetic Obesity Drug Product Market Performance
9.2.4 Sanofi. Business Overview
9.2.5 Sanofi. Genetic Obesity Drug SWOT Analysis
9.2.6 Sanofi. Recent Developments
9.3 Tonghua Dongbao Pharmaceutical Co., Ltd.
9.3.1 Tonghua Dongbao Pharmaceutical Co., Ltd. Genetic Obesity Drug Basic Information
9.3.2 Tonghua Dongbao Pharmaceutical Co., Ltd. Genetic Obesity Drug Product Overview
9.3.3 Tonghua Dongbao Pharmaceutical Co., Ltd. Genetic Obesity Drug Product Market Performance
9.3.4 Tonghua Dongbao Pharmaceutical Co., Ltd. Genetic Obesity Drug SWOT Analysis
9.3.5 Tonghua Dongbao Pharmaceutical Co., Ltd. Business Overview
9.3.6 Tonghua Dongbao Pharmaceutical Co., Ltd. Recent Developments
9.4 Biocon.
9.4.1 Biocon. Genetic Obesity Drug Basic Information
9.4.2 Biocon. Genetic Obesity Drug Product Overview
9.4.3 Biocon. Genetic Obesity Drug Product Market Performance
9.4.4 Biocon. Business Overview
9.4.5 Biocon. Recent Developments
9.5 Adocia
9.5.1 Adocia Genetic Obesity Drug Basic Information
9.5.2 Adocia Genetic Obesity Drug Product Overview
9.5.3 Adocia Genetic Obesity Drug Product Market Performance
9.5.4 Adocia Business Overview
9.5.5 Adocia Recent Developments
9.6 GlaxoSmithKline Plc.
9.6.1 GlaxoSmithKline Plc. Genetic Obesity Drug Basic Information
9.6.2 GlaxoSmithKline Plc. Genetic Obesity Drug Product Overview
9.6.3 GlaxoSmithKline Plc. Genetic Obesity Drug Product Market Performance
9.6.4 GlaxoSmithKline Plc. Business Overview
9.6.5 GlaxoSmithKline Plc. Recent Developments
9.7 Novo Nordisk A/S.
9.7.1 Novo Nordisk A/S. Genetic Obesity Drug Basic Information
9.7.2 Novo Nordisk A/S. Genetic Obesity Drug Product Overview
9.7.3 Novo Nordisk A/S. Genetic Obesity Drug Product Market Performance
9.7.4 Novo Nordisk A/S. Business Overview
9.7.5 Novo Nordisk A/S. Recent Developments
9.8 Oramed Pharmaceuticals, Inc
9.8.1 Oramed Pharmaceuticals, Inc Genetic Obesity Drug Basic Information
9.8.2 Oramed Pharmaceuticals, Inc Genetic Obesity Drug Product Overview
9.8.3 Oramed Pharmaceuticals, Inc Genetic Obesity Drug Product Market Performance
9.8.4 Oramed Pharmaceuticals, Inc Business Overview
9.8.5 Oramed Pharmaceuticals, Inc Recent Developments
9.9 Wockhardt.
9.9.1 Wockhardt. Genetic Obesity Drug Basic Information
9.9.2 Wockhardt. Genetic Obesity Drug Product Overview
9.9.3 Wockhardt. Genetic Obesity Drug Product Market Performance
9.9.4 Wockhardt. Business Overview
9.9.5 Wockhardt. Recent Developments
9.10 Eli Lilly and Company.
9.10.1 Eli Lilly and Company. Genetic Obesity Drug Basic Information
9.10.2 Eli Lilly and Company. Genetic Obesity Drug Product Overview
9.10.3 Eli Lilly and Company. Genetic Obesity Drug Product Market Performance
9.10.4 Eli Lilly and Company. Business Overview
9.10.5 Eli Lilly and Company. Recent Developments
9.11 Merck and Co., Inc.
9.11.1 Merck and Co., Inc. Genetic Obesity Drug Basic Information
9.11.2 Merck and Co., Inc. Genetic Obesity Drug Product Overview
9.11.3 Merck and Co., Inc. Genetic Obesity Drug Product Market Performance
9.11.4 Merck and Co., Inc. Business Overview
9.11.5 Merck and Co., Inc. Recent Developments
9.12 Julphar.
9.12.1 Julphar. Genetic Obesity Drug Basic Information
9.12.2 Julphar. Genetic Obesity Drug Product Overview
9.12.3 Julphar. Genetic Obesity Drug Product Market Performance
9.12.4 Julphar. Business Overview
9.12.5 Julphar. Recent Developments
9.13 Bristol-Myers Squibb Company.
9.13.1 Bristol-Myers Squibb Company. Genetic Obesity Drug Basic Information
9.13.2 Bristol-Myers Squibb Company. Genetic Obesity Drug Product Overview
9.13.3 Bristol-Myers Squibb Company. Genetic Obesity Drug Product Market Performance
9.13.4 Bristol-Myers Squibb Company. Business Overview
9.13.5 Bristol-Myers Squibb Company. Recent Developments
10 Genetic Obesity Drug Market Forecast by Region
10.1 Global Genetic Obesity Drug Market Size Forecast
10.2 Global Genetic Obesity Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Genetic Obesity Drug Market Size Forecast by Country
10.2.3 Asia Pacific Genetic Obesity Drug Market Size Forecast by Region
10.2.4 South America Genetic Obesity Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Genetic Obesity Drug by Country
11 Forecast Market by Type and by Application (2024-2031)
11.1 Global Genetic Obesity Drug Market Forecast by Type (2024-2031)
11.1.1 Global Forecasted Sales of Genetic Obesity Drug by Type (2024-2031)
11.1.2 Global Genetic Obesity Drug Market Size Forecast by Type (2024-2031)
11.1.3 Global Forecasted Price of Genetic Obesity Drug by Type (2024-2031)
11.2 Global Genetic Obesity Drug Market Forecast by Application (2024-2031)
11.2.1 Global Genetic Obesity Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Genetic Obesity Drug Market Size (M USD) Forecast by Application (2024-2031)
12 Conclusion and Key Findings